Published in Blood Weekly, October 23rd, 1995
He says one approach involving genetic modification of the donor should cut the risk of rejection and provide hope to the tens of thousands of Americans who die each year waiting for donor organs.
Anti-rejection drugs have transformed transplants into the treatment of choice for chronic organ failure. However, the overall shortage of donor organs is the biggest problem now facing such patients, the vast majority of whom never...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.